23andMe expands collaboration with Genentech

01/31/2013 | GenomeWeb Daily News (free registration)

23andMe is asking for saliva samples from any U.S. patient who used Avastin before this year to treat certain metastatic cancers. Study participants will be asked to send a saliva sample and may also submit a blood sample for genetic analysis, and will complete five online surveys throughout the year. The study, called InVite, aims to identify new genetic markers for the diseases and to understand differences in patient response.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC